Table 6 Resistance profile of Gram-positive bacteria identified from UTI patients. AMR antimicrobial resistance, DOX doxycycline, FOX cefoxitin, GEN gentamycin, NOR norfloxacin, PEN penicillin, R resistant isolates in percentage, SXT trimethoprim-sulfamethoxazole, T total number of tested isolates, VAN Vancomycin.
Antimicrobial tested | Number of Isolates (n = 48) | |||||
|---|---|---|---|---|---|---|
Classes | Antibiotics | S. aureus (n = 23) | S. saprophyticus (n = 25) | Total (n = 48) | ||
T | R (%) | T | R (%) | R (%) | ||
Glycopeptide | VAN | 23 | 9 (39.1%) | 25 | 9 (36%) | 18 (37.5%) |
Aminoglycosides | GEN | 23 | 2 (8.7%) | 25 | 3 (12%) | 5 (22.9%) |
Tetracyclines | DOX | 23 | 7 (30.4%) | 25 | 4 (14.3%) | 11 (33.0%) |
Beta-Lactams | PEN | 23 | 18 (78.3%) | 25 | 12 (48%) | 30 (62.5%) |
FOX | 23 | 14 (60.9%) | 25 | 7 (28%) | 21 (43.8%) | |
Sulfonamides | SXT | 23 | 8 (34.8%) | 25 | 7 (28%) | 15 (31.3%) |
Fluoroquinolones | NOR | 23 | 7 (30.4%) | 25 | 9 (36%) | 16 (33.3%) |
Overall AMR for a bacterium | 161 | 65 (40.4%) | 175 | 51 (29.1%) | (34.5%) | |
Overall AMR for isolates | Total tested isolates 336, Resistant isolates 116 (34.5%) | |||||
